Medicine and Dentistry
Patient
72%
Therapeutic Procedure
64%
Personalized Medicine
46%
Hematological Cancer
34%
Health Care Cost
32%
Gene
29%
Accuracy
29%
Overall Survival
24%
Multiple Myeloma
22%
Oncology
22%
Malignant Neoplasm
21%
Mucositis
21%
Patient Positioning
21%
B Lymphocyte Subpopulation
21%
Patient Registry
21%
Diagnosis
17%
Enalapril Maleate
15%
Neoplasm
14%
Analysis
14%
Radiation Therapy
14%
Lung Cancer
13%
Chemotherapeutic Agent
13%
Drug
13%
Cancer Treatment
12%
Hospital
10%
Mortality
10%
Diseases
10%
Development
9%
Anticarcinogen
9%
Gene Expression Profiling
9%
Tissues
9%
Non Small Cell Lung Cancer
9%
Combination Therapy
7%
Tonsil
7%
Progressive Disease
6%
Medicine
6%
Proportional Hazards Model
6%
Liver Metastasis
6%
Cancer Registry
6%
Inpatient
6%
Learning
6%
Patient with Cancer
6%
Relapse
5%
Gene Expression
5%
Health
5%
Nursing and Health Professions
Patient
100%
Personalized Medicine
31%
Overall Survival
21%
Mucosa Inflammation
21%
Indicator
21%
Mortality
19%
Inpatient
17%
Combination Therapy
17%
Lung Cancer
13%
Quality of Life
10%
Non Small Cell Lung Cancer
9%
Random Forest
9%
Death
7%
Researcher
7%
Malignant Neoplasm
6%
Clinician
6%
University Hospital
6%
Enalapril Maleate
6%
Liver Metastasis
6%
Cancer Registry
6%
Procedures
6%
Decision Support System
6%
Patient-Reported Outcome
5%
Pharmacology, Toxicology and Pharmaceutical Science
Immune Checkpoint Inhibitor
42%
Overall Survival
24%
Multiple Myeloma
22%
Indicator
21%
Mucosa Inflammation
21%
Malignant Neoplasm
18%
Enalapril Maleate
15%
Drug
13%
Prospective Study
12%
Neoplasm
11%
Diseases
10%
Lung Cancer
9%
Mortality
9%
Anticarcinogen
9%
Non Small Cell Lung Cancer
9%
Prognosis
9%
Squamous Cell Carcinoma
7%
Liver Metastasis
6%